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Abstract.  Recently, we established an in vitro model with immortalized dog uterine stromal (DUS) cells for investigations 
into canine-specific decidualization. Their capability to decidualize was assessed with cAMP and prostaglandin (PG) E2. 
Here, we show that the effects of PGE2 are mediated through both of the cAMP-mediating PGE2 receptors (PTGER2/4). 
Their functional inhibition suppressed gene expression of PRLR and PGR in DUS cells. We also assessed the effects of cAMP 
and PGE2 on selected extracellular matrix components and CX43, and showed that cAMP, but not PGE2, increases COL4, 
extracellular matrix protein 1 (ECM1) and CX43 protein levels during in vitro decidualization, indicating a mesenchymal-
epithelial decidual transformation in these cells. Thus, although PGE2 is involved in decidualization, it does not appear 
to regulate extracellular matrix. Further, the role of progesterone (P4) during in vitro decidualization was addressed. P4 
upregulated PRLR and PGR in DUS cells, but these effects were not influenced by PGE2; both P4 and PGE2 hormones 
appeared to act independently. P4 did not affect IGF1 expression, which was upregulated by PGE2, however, it suppressed 
expression of IGF2, also in the presence of PGE2. Similarly, P4 did not affect PGE2 synthase (PTGES), but in the presence 
of PGE2 it increased PTGER2 levels and, regardless of the presence of PGE2, suppressed expression of PTGER4. Our 
results indicate a reciprocal regulatory loop between PGE2 and P4 during canine in vitro decidualization: whereas P4 may 
be involved in regulating PGE2-mediated decidualization by regulating the availability of its receptors, PGE2 regulates PGR 
levels in a manner dependent on PTGER2 and -4.
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 (J. Reprod. Dev. 66: 319–329, 2020) 
T
he establishment and maintenance of pregnancy requires a precise 
and orchestrated interplay between fetal trophoblast and maternal 
tissues, involving dynamic changes of the hormonal axis and species-
specific morpho-functional changes in the uterus. In this context, 
during early pregnancy uterine immune, epithelial and stromal cells 
interact with each other, facilitating the successful onset of pregnancy 
(reviewed in [1, 2]). Consequently, in species exhibiting invasive types 
of placentation, maternal stroma-derived decidual cells develop. This 
species-specific tissue remodeling is referred to as decidualization, 
and is one of the most essential events at the beginning of pregnancy 
in rodents, carnivores and humans [3–6]. In rodents [6] and dogs 
[7, 8] maternal decidual cells of mesenchymal origin are formed 
in response to the presence of implanting blastocysts, whereas in 
humans decidua is spontaneously formed during every reproductive 
cycle in a progesterone (P4)-dependent manner (reviewed in [9]). 
Contrasting with the haemochorial type of placentation, and peculiar 
to the endotheliochorial type of placentation observed in carnivores 
including the dog, decidual cells together with maternal vascular 
endothelium can escape the proteolytic activity of trophoblast. 
Considering the importance of P4 in the maintenance of pregnancy, 
in the dog decidual cells are the only cells expressing the nuclear 
progesterone receptor (PGR) [10, 11], which is a species-specific 
feature. Despite being devoid of its own steroidogenic activity, 
due to the presence of PGR in its maternal component the canine 
placenta can respond to circulating luteal P4. Interfering with its 
function alters feto-maternal communication, leads to prepartum 
PGF2α synthesis, and terminates pregnancy in dogs (reviewed in [5, 
12]). The central role of decidual cells in canine pregnancy becomes 
apparent when PGR-antagonists are applied, unequivocally leading 
to termination of pregnancy [10]. Clearly, thus, in agreement with 
the main goal of our studies, detailed investigations are needed into 
the decidualization process in the dog to improve its understanding, 
to increase clinical opportunities for more targeted management of 
pregnancies, and to control reproductive processes in this species.
At present, in the dog the development of decidual cells is still 
not well understood. Therefore, recently, we established a cellular 
in vitro model of canine decidualization using uterine stromal cells 
isolated from naturally estrogenized early diestric bitches [13]. Taking 
it further, a DUS (dog uterine stromal) cell line was generated [7]. 
DUS cells were morphologically and biochemically characterized, 
becoming a reliable model for investigating in vitro decidualization 
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in this species [7]. We also established that prostaglandin (PG) E2 
is capable of inducing the expression of canine decidualization 
markers in DUS cells, such as prolactin receptor (PRLR), PGR, 
PGE2-synthase (PTGES) and PGE2 receptor 4 (PTGER4/EP4) [7]. 
In this, similarities were found between the early decidualization 
processes in dogs and those in rodents and humans [14–16].
In fact, in vivo as well the PGE2-system appears to be involved 
in the decidualization process in the dog as it was found in epithelial 
and stromal compartments of the early pregnant uterus [8], and 
PGE2-synthesizing PTGES is abundantly expressed in free-floating 
blastocysts [8]. The potential involvement of particular PGE2 receptors 
in the underlying processes remains, however, to be shown. Due 
to dependence of the decidualization process on cAMP and/or its 
inducing stimuli [7, 13, 17], the present study was based on the 
hypothesis that PTGER2/EP2 and PTGER4/EP4 are involved in the 
underlying processes. Both PTGER2 and -4 act via the cAMP/PKA 
pathway [18]. Canine in vivo early decidualization is accompanied 
by extracellular matrix (ECM) remodeling [19]. This involves, e.g., 
the expression of fibronectin (FN) 1, extracellular matrix protein 1 
(ECM1) and tissue inhibitor of metalloproteinases (TIMP) 2 and -4 
[19, 20]. Furthermore, implantation and trophoblast invasion are also 
associated with strong structural changes in the uterus, characterized 
by modulation of collagen expression levels [19]. The contribution of 
the decidual cell compartment to matrix remodeling in the dog during 
both in vitro and in vivo decidualization remains, however, to be 
determined. This applies also to the PGE2-dependent mechanisms. So 
far, we have shown that primary DUS cells secrete increased amounts 
of proteins during cAMP-mediated decidualization [13]. Similarly, 
in mice, stromal cell lines secrete basement membrane components 
[21]. Interestingly, in both pregnant and non-pregnant animals the 
canine uterus is physiologically exposed to high P4 concentrations 
(see reviews in [5, 12, 22, 23]). P4 profiles and concentrations are 
similar in both situations [24], however, they do not lead to spontane-
ous decidualization as observed in humans. Possible interactions 
between PGE2 and P4-dependent mechanisms are indicated due 
to the PGE2-dependent induction of PGR expression in DUS cells 
in vitro [7]. These synergistic effects and the involvement of the 
respective PGE2-receptors in the underlying mechanisms need to 
be investigated.
Here, we utilized our proven in vitro decidualization model with 
immortalized DUS cells to fill existing knowledge gaps. The main 
goals of the project were: i) to investigate the potential involvement 
of PTGER2/4 in PGE2-dependent decidualization, ii) to assess 
the effects of cAMP and PGE2 on matrix remodeling, and iii) to 
demonstrate the potential synergistic effects of PGE2 and P4 during 
canine decidual cell formation.
Material and Methods
Cell culture and in vitro experiments with DUS cells
The DUS cell line was utilized for the present study [7]. The 
handling and stimulation of the cell culture followed the basic pro-
cedure as previously published [7, 13]. Briefly, after trypsinization 
and harvesting, cells were transferred into 6-well plates (TPP Techno 
Plastic Products AG, Trasandingen, Switzerland) at a concentration 
of 1 × 105 cells per well. For immunofluorescence (IF) staining, 
sterile glass cover slips were placed into the well, then cells were 
seeded onto them to allow adhesion to take place. After transferring 
the cells into the plates, prior to treatments, they were kept for 24 
h under standard culture conditions (i.e., 37°C, 5% CO2 in air, in 
a humidified incubator) in fresh cell culture medium consisting 
of DMEM-High Glucose (Bio Concept, Allschwil, Switzerland), 
pH 7.2–7.4, with 10% heat-inactivated FBS (Fetal Bovine Serum; 
Thermo Scientific AG, Reinach, Switzerland), 100 U/ml penicillin 
and 100 µg/ml streptomycin (PAN Biotech, Aidenbach, Germany) 
and 1% ITS (Insulin-Transferrin-Selenium; Corning from Thermo 
Scientific AG). The standard decidualization protocol with N6,2′-O-
dibutyryladenosine-3′,5′-cyclicmonophosphate (dbcAMP, referred 
further to as cAMP) was applied as previously described [7, 13]. In 
short, after washing with PBS, cells were incubated with stimulation 
medium (cell culture medium with 0.1% bovine serum albumin (BSA) 
instead of FBS). Decidualization was induced with 0.5 mM cAMP 
(D0627, Sigma-Aldrich Chemie GmbH, Buchs, Switzerland) during 
72 h [7, 25]. Moreover, DUS cells were incubated (i.e., decidualized) 
for 72 h with 10 µM PGE2 (P0409, Sigma-Aldrich) in stimulation 
medium, while stimulation medium without additives was used 
for a control. Both cAMP and PGE2 concentrations were derived 
from our previous studies [7, 13]. DUS cells were also incubated 
with stimulation medium that contained increasing dosages of P4 
(P8783, Sigma-Aldrich) (0.01 µM = 10–8 M, 0.1 µM = 10–7 M, 
1.0 µM = 10–6 M) alone or in combination with 10 µM PGE2. 
Selective blockers of PGE2 receptors (functional inhibition) from 
Cayman Chemical, Ann Arbor, MI, USA, were used targeted against 
PTGER2/EP2 (PF-04418948) and PTGER4/EP4 (GW-627368X). 
They were applied at increasing dosages (0.1 µM, 1.0 µM, 10 µM) 
in stimulation medium.
At least three consecutive experiments were performed for all cell 
culture experiments. The DM IL LED Fluo (Leica Microsystems 
CMS GmbH, Wetzlar, Germany) was used as an inverted bright field 
microscope and a LeicaDMI 6000B device served as the fluorescence 
microscope.
RNA isolation, reverse transcription (RT) and semi-quantitative 
(TaqMan) PCR
After the standard cell culture incubation period of 72 h, DUS cells 
were washed with cold PBS and harvested with TRIzol® reagent 
(Invitrogen, Carlsbad, CA, USA). Detailed information about the 
following steps has been published before [13, 19, 26]. In short, from 
each sample 10 ng total RNA were used for RQ1 RNase-free DNase 
treatment (Promega, Dübendorf, Switzerland). This was followed 
by the use of the High Capacity cDNA Reverse Transcription Kit 
including RNase Inhibitor (Applied Biosystems from Thermo Fisher 
Scientific). Amplification of cDNA was performed according to 
the supplier՚s protocol with the TaqMan PreAmp Master Mix Kit 
(Applied Biosystems). TaqMan PCR was run in duplicates with 
the Fast Start Universal Probe Master (ROX) (Roche Diagnostics 
AG, Rotkreutz, Switzerland) in an automated fluorometer (ABI 
PRISM 7500 Sequence Detection System, Applied Biosystems). 
Controls consisted of running experiments with autoclaved water 
instead of cDNA and genomic DNA contamination was checked by 
the so-called RT-minus control [26, 27]. Table 1 presents a list of 
all TaqMan systems used for the present study. In-house designed 
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Table 1. List of all TaqMan systems used for semi-quantitative RT-PCR
Primer Accession number Primer Sequence Product 
length (bp)
Extracellular Matrix Protein 1 
(ECM1)
XM_845921.4 Forward 5´-CAG TCT GGC TTC TCC CAC CTT A-3´ 99
Reverse 5´-GCG GTT TGT GTG GCT GTG A-3´
TaqMan Probe 5´-AGA CTA GAT ATT CCC GCT GCT GCC GCT-3´
Connexin 26 (CX26/GJB2) AJ439693.1 Forward 5´-CCA CTA CTT CCC CAT CTC TCA CA-3´ 98
Reverse 5´-TCC GGT AGG CGA CAT GCA T-3´
TaqMan Probe 5´-CCG ACT CTG GGC TCT GCA GCT GAT C-3´
Connexin 43 (CX43/GJA1) AY462223 Forward 5´-AAA AGA GAA CCC TGC CCT CAT C-3´ 91
Reverse 5´-AGG ACA CGA CCA GCA TGA AGA-3´
TaqMan Probe 5´-ACT GCT TCC TCT CTC GCC CCA CG-3´
Fibronectin 1 (FN1) XM_014110981 Forward 5´-CAC GCC GAA CTA CGA TGC-3´ 95
Reverse 5´-TGC GAT ACA TGA CCC CTT-3´
TaqMan Probe 5´-AAG TTT GGA TTT TGC CCC ATG GCC-3´
Laminin alpha 2 (LAMA2) XM_014113700.1 Forward 5´-AAA CCG GCT CAC GAT TGA G-3´ 99
Reverse 5´-AGT TGA ACG GTG GCG AAG T-3´
TaqMan Probe 5´-CCT GCT CTT CTA CAT GGC TCG GAT CAA-3´
Glyceraldehyd 3-phosphate 
dehydrogenase (GAPDH)
AB028142 Forward: 5´-GCT GCC AAA TAT GAC GAC ATC A-3´ 75
Reverse: 5´-GTA GCC CAG GAT GCC TTT GAG-3´
TaqMan Probe 5´-TCC CTC CGA TGC CTG CTT CAC TAC CTT-3´
Progesterone receptor (PGR) NM_001003074 Forward: 5´-CGA GTC ATT ACC TCA GAA GAT TTG 1 1 1-3´ 113
Reverse: 5´-CTT CCA TTG CCC TTTTAA AGA AG A-3´
TaqMan Probe 5´-AAG CAT CAG GCT GTC ATT ATG GTG TCC TAA CTT-3´
Prostaglandin E2 synthase (PTGES) NM_001122854 Forward: 5´-GTC CTG GCG CTG GTG AGT-3´ 89
Reverse: 5´-ATG ACA GCC ACC ACG TAC ATC-3´
TaqMan Probe 5´-TCC CAG CCTTCC TGC TCT GCA GC-3´
Prostaglandin E2 receptor 2 
(PTGER2/EP2)
AF075602 Forward: 5´-CAC CCT GCT GCT GCT TCT C-3´ 78
Reverse: 5´-CGG TGC ATG CGG ATG AG-3´
TaqMan Probe 5´-TGC TCG CCT GCA ACTTTC AGC GTC-3´
Prostaglandin E2 receptor 4 
(PTGER4/EP4)
NM_001003054 Forward: 5´-AAA TCA GCA AAA ACC CAG ACT TG-3´ 96
Reverse: 5´-GCA CGG TCT TCC GCA GAA-3´
TaqMan Probe 5´-ATC CGA ATT GCT GCT GTG AAC CCT ATC C-3´
Prolactin receptor (PRLR) HQ267784 Forward: 5´-GGA TCT TTG TGG CCG TTC TTT-3´ 92
Reverse: 5´-AAG GAT GCA GGT CAC CAT GCT AT-3´
TaqMan Probe 5´-ATT ATG GTC GTA GCA GTG GCT TTG AAA GGC-3´
Tissue inhibitor of matrix 
metalloproteinase-2
(TIMP2)
AF188489 Forward 5´-CAT AGG TAC CAG ATG GGC TGT GA-3´ 95
Reverse 5´-CAG TCC ATC CAG AGG CAC TCA-3´
TaqMan Probe 5´-TGA TCC CGT GCT ATA TCT CGT CTC CGG-3´
Tissue inhibitor of matrix 
metalloproteinase-2
(TIMP4)
NM_001314106 Forward 5´-CTG TGG CTG CCA AAT TAC CA-3´ 103
Reverse 5´-CCC ATA GAG CTT CCG TTC CA-3´
TaqMan Probe 5´-ACC ATC TCA GCC CCT AAC GAG TGC CTC-3´
Cyclophilin (PPIA) XM_843327.1 Applied Biosystems, prod nr. Cf03986523_gH 92
Insulin-like growth factor 1 (IGF1) NM_001313855.1 Applied Biosystems, prod nr. Cf02627846_m1 104
Insulin-like growth factor 2 (IGF2) NM_001195403 Applied Biosystems, prod nr. Cf02647136_m1 126
ActinB NM_001003349.1 Applied Biosystems, prod nr. Cf03023880_g1 121
Collagen, type 1, alpha 1 (COL1A1) NM_001003090 Applied Biosystems, prod nr. Cf02741575_mH 97
Collagen, type 3, alpha 1 (COL3A1) XM_845916 Applied Biosystems, prod nr. Cf02631366_m1 98
Collagen, type 4, alpha 1 (COL4A1) XM_014106444 Applied Biosystems, prod nr. Cf02696157_mH 82
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systems were purchased from Microsynth (Balgach, Switzerland) 
and were validated by a probe efficiency test as previously described 
[26, 27]. FAM- and TAMRA-labeled, pre-designed, commercially 
available TaqMan systems were ordered from Applied Biosystems. 
Three reference genes were used for normalization: glycerinaldehyd-
3-phosphat-dehydrogenase (GAPDH), cyclophilin A and actinB. 
The calculation of fold gene expression values was as previously 
reported [26]. Briefly, qPCR was performed in duplicates and the 
average Ct values were determined by calculating the arithmetic 
means. The average Ct values were used to calculate ΔCt. Next, the 
sample with the lowest expression was selected as the calibrator. 
This was followed by calculating ΔΔCt and the fold gene expression. 
The statistical analysis was performed with log transformed values.
IF staining, CellProfiler and evaluation of data
IF staining was performed as previously described [7, 28]. In 
short, following the standard cell culture incubation period of 72 h, 
the cells adhering to a sterile glass cover slip were fixed by adding 
formalin to the incubation medium to a final concentration of 2%, for 
10 min at 37°C. Following glycine treatment (5 min) and blocking 
with goat serum (30 min), the primary antibody was incubated for 
2 h at ambient temperature. The list of antibodies and their specific 
dilutions can be found in Table 2. Following incubation with the 
secondary antibody (equipped with either Alexa Fluor 594 or Alexa 
Fluor 466 dyes) in combination with 4′,6-diamidino-2-phenylindole 
(DAPI; Sigma-Aldrich) used at a concentration of 1:1000, the glass 
cover slip was mounted using Glycergel® (Sigma-Aldrich) on a 
microscope slide and representative pictures were taken with the 
LeicaDMI 6000B fluorescence microscope equipped with a Leica 
DFC360FX camera. Controls were used as previously published [7, 
10, 13], i.e., staining with only primary or secondary antibodies was 
performed as well as omitting any antibody to check for autofluores-
cence. Additional controls consisted of vimentin (mesenchymal cell 
marker), and SV40Tag (nuclear marker of immortalization) staining.
Next, the open-source software CellProfiler 3.0.0 [29] was used 
to determine the IF intensity of selected ECM proteins and to count 
the number of cells per field of view. Following IF co-staining [i.e., 
DNA staining with DAPI in addition to ECM-proteins staining against 
aminin alpha 2 (LAMA2), extracellular matrix protein 1 (ECM1), 
connexin 43 (CX43) or collagen type 4 (COL4)], the LeicaDMI 
6000B fluorescence microscope equipped with a Leica DFC360FX 
camera was used to take 6 pictures of random view fields with a 
63× dry magnification lens. At least 3 consecutive experiments were 
investigated independently. Software settings of CellProfiler 3.0.0 
were adjusted according to either nuclei count or to ECM signal 
detection as described before [29]. DAPI staining was used to count 
cell nuclei per field of view. To ensure that the same number of cells 
was investigated in both conditions, nuclei counts were summed for 
each condition (i.e., the control well and the cAMP-stimulated well) 
and experiment individually and adjusted to each other by omitting 
single pictures for further analysis. A count of at least 200 cells and 
a difference between control and cAMP condition of +/– 10 cells 
were the minimum requirements for the adjustment. Following this, 
the remaining pictures were analyzed for the mean fluorescence 
intensity of ECM target protein (i.e., LAMA2, ECM1, CX43 or 
COL4). At least three consecutive experiments were independently 
evaluated from each other.
Statistics
Statistics were performed with GraphPad 3.06 Software (GraphPad 
Software, San Diego, CA, USA) for the normalized TaqMan ΔΔCt 
values and the mean IF intensity. For all performed statistics the data 
had to pass the statistical assumptions for normality and equality of 
variances. TaqMan experiments were evaluated with a parametric 
one-way ANOVA. In the case of P < 0.05 (i.e., difference among 
values was considered significant), the Tukey-Kramer multiple 
comparisons post-test was performed. The mean IF intensity was 
evaluated through an unpaired two-tailed Student’s t-test. Numerical 
data are presented as geometric means Xg +/– geometric standard 
deviation (SD).
Results
cAMP, but not PGE2, modulates the expression of ECM-
related factors during in vitro decidualization of DUS cells
The mesenchymal character of DUS cells presented previously [7] 
was confirmed herein (Fig. 1A, B). They exhibit vimentin staining 
and show stable genomic incorporation of the pSV40Tag (marker of 
immortalization) in their genome. Next, DUS cells were decidualized 
in vitro using 0.5 mM cAMP or 10 µM PGE2 as indicated in Material 
and Methods, and the expression of selected ECM-related factors 
was evaluated on the mRNA level for the following genes: COL1, 
COL3, COL4, ECM1, LAMA2, FN1, CX26, CX43, TIMP2 and TIMP4. 
Whereas LAMA2 expression was significantly suppressed during 
cAMP-mediated decidualization (P < 0.001), the mRNA levels of 
ECM1, CX43 and COL4 were upregulated (P < 0.001) (Fig. 1C), 
Table 2. List of primary and secondary antibodies used for immunofluorescence staining
Antibody Company Reference Number Host Dilution
Collagen IV (COL4) Abcam ab6586 rabbit polyclonal 1:300
Laminin 2 alpha (LAMA2) Bioss Antibodies bs-8561R rabbit polyclonal 1:100
Connexin 43 (CX43/GJA1) Abcam ab11370 rabbit polyclonal 1:400
Extracellular Matrix Protein 1 (ECM1) Proteintech 11521-1-AP rabbit monoclonal 1:100
Vimentin Abcam ab92547 rabbit monoclonal 1:500
SV40T-antigen (SV40Tag) Abcam ab16879 mouse monoclonal 1:500
Alexa fluor 594 goat anti-rabbit IgG (H+L) Invitrogen A11037 goat 1:100
Alexa fluor 488 goat anti-mouse IgG (H+L) Invitrogen A11029 goat 1:100
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and were significantly more highly expressed (P < 0.001) than in 
PGE2-treated cells. PGE2 did not show any significant effects on the 
expression of ECM-related target genes (P > 0.05). Neither cAMP 
nor PGE2 had any effect on the expression of COL1, COL3, FN1, 
CX26, or TIMP2 and TIMP4 (P > 0.05, data not shown).
In the next step, the ECM-associated genes that were significantly 
altered at the mRNA level during cAMP-mediated decidualization 
were further analyzed at the protein level by measuring the mean IF 
intensity. In Fig. 1D, representative IF pictures are shown of DUS 
cells treated with or without cAMP and stained against LAMA2, 
ECM1, CX43 or COL4. For every experiment, 6 pictures were taken 
from randomly chosen areas and submitted to CellProfiler and the 
mean IF intensity was determined. Whereas the mean IF intensity 
of LAMA2 did not differ significantly (P > 0.05) between control 
and cAMP conditions, the intensity of ECM1, CX43 and COL4 
increased following the treatment (P < 0.05) (Fig. 1E).
PGE2-mediated expression of PRLR and PGR in DUS cells is 
PTGER2/EP2- and PTGER4/EP4-dependent
DUS cells were decidualized in vitro with PGE2 following the 
application of increasing dosages of specific functional blockers of 
PTGER2 or PTGER4. The gene expression level of PRLR, PGR as 
well as of PTGES and PTGER2 and -4 was assessed (Fig. 2). Both 
blockers significantly abolished the stimulatory effects of PGE2 on 
PRLR and PGR expression during the decidualization process. The 
PRLR expression was significantly suppressed (P < 0.05) with 1.0 
and 10 μM of PTGER2 blocker, and decreased gradually, reaching 
the lowest expression in response to 10 μM of the PTGER4 blocker 
(P < 0.001) (Fig. 2A, B). Similarly, PGR was significantly suppressed 
in response to 1.0 and 10 μM of PTGER2-blocker (P < 0.01 and 
P < 0.001, respectively). When PTGER4 blocker was applied, the 
PGR mRNA levels decreased gradually by P < 0.05, P < 0.01 and 
P < 0.001, in response to 0.1, 1.0 and 10.0 μM PTGER4 blocker, 
respectively (Fig. 2A, B). Neither of the blockers had a significant 
Fig. 1. Expression of selected extracellular matrix factors during cAMP- and prostaglandin (PG) E2-mediated in vitro decidualization of dog uterine 
stroma (DUS) cells. (A) Morphological appearance of DUS cells. (B) Expression of vimentin (mesenchymal cell marker; red color) and pSV40 Tag 
(marker of immortalization; green color) was verified by immunofluorescence (IF). (C–E) Cells were treated either with 10 µM PGE2 or with 0.5 
mM cAMP over a time course of 72 h. (C) Relative mRNA expression of selected extracellular matrix (ECM) factors and of CX43. A parametric 
one-way ANOVA was applied followed by the Tukey-Kramer multiple comparisons post-test. Numerical data are presented as geometric means 
Xg ± geometric standard deviation (SD). P-values < 0.05 were considered significant and are indicated. (D) Representative IF staining of laminin 
alpha 2 (LAMA2), extracellular matrix protein 1 (ECM1), connexin 43 (CX43) and collagen type 4 (COL4) in control and cAMP-stimulated 
DUS cells (target protein = red color, DAPI = nuclear staining, blue color), and (E) corresponding quantification of selected protein expression as 
determined by mean IF intensity. Statistical differences were determined by an unpaired two-tailed Student’s t-test. Numerical data are presented 
as geometric means Xg ± SD. P-values are indicated.
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effect on expression of the PGE2 system, i.e., PTGES and the two 
receptors (PTGER2/4) (P > 0.05, data not shown).
The effects of progesterone (P4) on expression of 
decidualization markers
DUS cells were treated for 72 h with cAMP or PGE2 (positive 
controls) or with increasing P4 concentrations in the absence (left-hand 
side) or presence (right-hand side) of PGE2 (Figs. 3, 4). The expression 
of PRLR, PGR, IGF1 and IGF2 was investigated (Fig. 3), as well as 
of the PGE2-system, i.e., PTGES, PTGER2 and PTGER4 (Fig. 4). 
Whereas cAMP significantly increased the mRNA levels of PRLR, 
PGR and IGF1 (P < 0.001, P < 0.01 and P < 0.001, respectively), the 
expression of IGF2 was suppressed by cAMP (P < 0.001) (Fig. 3).
PRLR and PGR gradually increased significantly in response to 
increasing P4 concentrations, reaching the highest concentrations in 
response to 10–6 mM P4. The stimulatory effects of P4 on its own 
receptor (PGR) were stronger than that of cAMP (P < 0.05 at 10–6 
mM P4). Interestingly, while IGF1 was not affected by treatment 
with P4, IGF2 was significantly suppressed in response to increased 
concentration of P4 (P < 0.001).
When treated with PGE2, PRLR (P < 0.05), PGR (P < 0.05) 
and IGF1 (P < 0.001) were significantly elevated compared with 
Fig. 2. Functional blocking of PGE2 receptor 2 (PTGER2/EP2) and PGE2 receptor 4 (PTGER4/EP4) in decidualizing dog uterine stroma (DUS) cells. 
Expression of prolactin receptor (PRLR) and progesterone receptor (PGR) as determined by real time (TaqMan) PCR. Selective PTGER2 (A) or 
PTGER4 (B) blockers were used as described in Material and Methods. A parametric one-way ANOVA was applied followed by the Tukey-Kramer 
multiple comparisons post-test. Numerical data are presented as geometric means Xg ± geometric standard deviation (SD). P-values < 0.05 were 
considered significant and are indicated.
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non-treated controls. These effects were not altered for either of these 
genes in the presence of P4 in the stimulation medium (P > 0.05). 
This was, however, not the case for IGF2. Thus, whereas it was not 
affected by PGE2 (P > 0.05) when applied at highest concentration 
(10–6 mM), P4 significantly suppressed IGF2 expression as well in 
the presence of PGE2 (P < 0.001) (Fig. 3).
As for the PGE2-system, the expression levels of PTGES, PTGER2 
and PTGER4 were upregulated in response to cAMP (P < 0.05 for 
PTGES and PTGER2, and P < 0.001 for PTGER4), whereas PGE2 
increased the mRNA levels of its own synthase PTGES (P < 0.05) 
and of PTGER4 (P < 0.05). With regard to the effects of P4, it 
significantly suppressed the expression of PTGER4 even when used 
at the lowest concentrations (P < 0.05 and P < 0.001, for 10–7 mM 
and 10–8 mM, respectively) (Fig. 4), but no P4 effects were noted 
for PTGES and PTGER2 mRNA levels (P > 0.05). However, when 
used in co-treatment, PGE2 together with P4 applied at the highest 
concentration (10–6 mM) had a positive effect on PTGER2 (P < 
0.001). As also revealed in co-treatment experiments, and already 
shown in single treatments, P4 suppressed the expression of PTGER4 
regardless of the presence of PGE2 in the stimulation medium (P < 
0.01 and P < 0.001 for 10–7 and 10–6 mM P4).
Discussion
Investigating the development and function of canine decidual 
cells appears to be one of the most important tasks required for better 
understanding of the physiology of canine pregnancy. Morphologically, 
in the dog, decidualization starts at the time of embryo implantation 
(around day 17 of embryonal life) with strong endometrial prolifera-
tion being associated with histological changes in the sub-epithelial 
stromal compartments [7]. The vimentin-positive, interstitial stromal 
cells become larger and rounded, undergoing morpho-functional 
decidualization [7]. These round cells with ovoid nuclei and dense 
chromatin were also previously found in the early pregnant canine 
uterus as NEP/CD10-negative cells sharing morphological resem-
blance with predecidual cells of women [30]. NEP/CD10 (neutral 
endopeptidase, neprylisin, enkephalinase) is a multifunctional protein 
and metalloprotease normally characteristic of uterine stromal cells 
[30]. Similar to humans, in the dog also stromal decidualization 
can be recapitulated in vitro and is associated with increased secre-
tory activity of decidualizing cells [7, 13]. Here, making use of 
the recently generated DUS cell line [7], and using our previously 
established cAMP- and PGE2-mediated approaches [7, 13], in vitro 
decidualization-associated expression of selected ECM-modulating 
compounds and of CX43 was investigated. All factors were clearly 
detectable in DUS cells during decidualization protocols. ECM1 and 
COL4 proteins were significantly increased in cAMP-stimulated cells. 
In addition to its function in extracellular matrix formation, ECM1 
has been shown to be involved in cellular differentiation, maturation 
and proliferation [31]. Additionally, it exhibits the potential to reduce 
proteolytic activities of some metalloproteinases, e.g., MMP9 [32]. 
Its involvement in regulating uterine and placental functions in the 
dog was suggested recently [19]. COL4 is a component of the basal 
lamina. Its increased expression in decidualized DUS cells implies 
the mesenchymal-epithelial decidual transition of uterine stromal 
compartments described previously for humans [33]. Thus, while 
continuously expressing vimentin and characterized by high levels 
of alpha-smooth muscles actin (αSMA) [7, 13], canine decidual cells 
appear to exhibit some epithelioid characteristics previously known 
from other cellular models of decidualization. Interestingly, in human 
decidualized stromal cells, elevated levels of COL4 were associated 
with decreased expression of NEP/CD10 [33], a further sign of 
epithelioid decidual transition. Also, similar to the situation observed 
in humans, we found an increase in connexin 43 (CX43) levels in 
decidualized cells, both at the mRNA and protein levels. This seems 
to be an important finding. As an adhesion and gap junction molecule, 
CX43 is also critical for differentiation of endometrial stromal cells 
in other species, e.g., in humans [34, 35]. Disruption of its function 
induces inflammatory mediators and leads to apoptosis of stromal 
cells [34, 35]. Cumulatively, our findings regarding ECM-related 
factors and CX43 indicate similarities between canine decidualization 
and the decidual mesenchymal-epithelial transition observed in 
humans. Corroborating these findings, recently, as revealed by a 
transcriptomic approach, we found a positive correlation between sets 
of genes expressed in the preimplantation canine uterus and genes 
expressed in the human uterus during the window of implantation 
[20]. The number of matching genes was higher than that detected in 
comparison with other domestic animal species (horse, pig and cattle), 
displaying a non-invasive placentation type. The close match between 
canine and human preimplantation endometrium was interpreted as a 
result of the ongoing decidualization process. Nevertheless, it needs 
to be re-emphasized that, in contrast with the situation observed in 
humans where decidualization is spontaneously cyclically induced 
by P4, in dogs as in rodents, decidualization is induced by uterine 
exposure to embryos and embryo-maternal contact [7, 20].
Contrasting with the cAMP-mediated approach, as presented 
herein, PGE2-driven decidualization did not affect the expression 
of investigated ECM components. This is an interesting observation. 
Thus, although revealing decidualization capacities, PGE2 does not 
seem to be strongly involved in regulating matrix assembly nor the 
expression of CX43 in canine decidual cells.
Adding to the previous facts regarding the role of PGE2 dur-
ing canine decidualization, in the present study, we were able to 
demonstrate that the PGE2-driven activation of PGR and PRLR 
expression is modulated by both cAMP/PKA-dependent PGE2 
receptors, i.e., PTGER2 and PTGER4. The functional suppression of 
their activity diminished the PGE2-driven expression of both PRLR 
and PGR. By including a mechanistic insight related to the PTGER2 
and -4 involvement in regulating PGR expression, the present study 
further emphasizes the previously postulated [7] interaction between 
PGE2 and P4-dependent mechanisms regulating canine uterine 
function during pregnancy. These species-specific regulatory features 
appear to be of translational importance for comparative research in 
other mammals. The mechanism of the possible amplification loop 
within the PGE2 system appears interesting and requires further 
investigations. Accordingly, PGE2 upregulates the expression of 
its own synthase (PTGES) and of the PTGER4 receptor, however, 
expression of the PGE2 system in decidualizing DUS cells treated 
with PTGER2/-4 blockers did not change significantly. This could 
be due to compensatory mechanisms existing between the two 
PGE2 receptors.
Although still not fully understood, the role of decidual cells in 
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Fig. 3.
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Fig. 4. Gene expression of PGE2-synthase (PTGES), PGE2 receptor 2 (PTGER2/EP2) and PGE2 receptor 4 (PTGER4/EP4) as determined by real time 
(TaqMan PCR). Dog uterine stroma (DUS) cells were stimulated with different dosages (10–6, 10–7, 10–8 mM) progesterone (P4), alone or in the 
presence of 10 µM PGE2; 0.5 mM cAMP was used as a positive control. The treatment was applied for 72 h. A parametric one-way ANOVA 
was applied followed by the Tukey-Kramer multiple comparisons post-test. Numerical data are presented as geometric means Xg ± geometric 
standard deviation (SD). P-values < 0.05 were considered significant and are indicated.
Fig. 3. Gene expression of prolactin receptor (PRLR), progesterone receptor (PGR), insulin-like growth factor 1 (IGF1) and insulin-like growth factor 2 
(IGF2) as determined by real time (TaqMan PCR). Dog uterine stroma (DUS) cells were stimulated with different dosages (10–6, 10–7,10–8 mM) 
of progesterone (P4), alone or in the presence of 10 µM PGE2; 0.5 mM cAMP was used as a positive control. The treatment was applied for 72 
h. A parametric one-way ANOVA was applied followed by the Tukey-Kramer multiple comparisons post-test. Numerical data are presented as 
geometric means Xg ± geometric standard deviation (SD). P-values < 0.05 were considered significant and are indicated. A logarithmic scale was 
used to present results for IGF1.
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the dog is largely determined by their expression of the nuclear PGR, 
which plays an important role during maintenance of pregnancy [10, 
36]. Thus, in the next step, by making use of DUS cells we were 
also able to investigate possible synergistic effects between P4 and 
PGE2 during in vitro decidualization. Such mechanisms exist for 
human stromal cells, in which PGE2 accelerates the P4-mediated 
decidualization [37]. Consequently, in our next experiments cells were 
treated with P4 alone or in co-treatment with PGE2. Both cAMP and 
PGE2 were used as positive controls, revealing increased expression 
of PRLR, IGF1, PGR and the PGE2-system following cAMP treat-
ment. Whereas in our previous experiments IGF2 expression, while 
displaying high variation, remained statistically unaffected, in the 
present experiments, it was clearly suppressed in cAMP-decidualized 
DUS cells. This was associated with very high IGF1 levels and could 
relate to yet undefined conditions, e.g., the culture medium or other 
experimentally-dependent variations of gene expression. However, 
it needs to be emphasized that, due to the restricted availability of 
canine-specific or cross-reacting antibodies, the present analysis was 
largely conducted at the messenger level. Until the expression of the 
respective proteins can be investigated, any final conclusion would be 
premature. As for PGE2, besides the above-mentioned positive effects 
on PRLR and PGR, PGE2 confirmed its capability to increase the 
expression of its own synthase (PTGES) and PTGER4. Additionally, 
IGF1 expression was significantly upregulated. Interestingly, when 
used alone, P4 upregulated the gene expression of PGR and PRLR, 
thereby revealing a basic capability to modulate the expression 
of both decidualization markers. Notably, the effects of P4 on the 
expression of its own receptor were stronger than those exerted by 
cAMP, implying a functional enhancement loop between P4 and PGR. 
These effects were not affected by PGE2, and both hormones, i.e., 
P4 and PGE2, appeared to act independently. Similarly, P4 did not 
change IGF1 expression, and neither did it influence the stimulatory 
effects of PGE2 on IGF1. In contrast, regardless of the presence of 
PGE2 in the stimulation medium, P4 diminished IGF2 mRNA levels 
in a dose-dependent manner. Nevertheless, P4 appears to possess a 
regulatory capability on the PGE2-system, by modulating PTGER2 
and -4 expression. Accordingly, when used in cotreatment with PGE2, 
at higher concentrations P4 upregulated PTGER2 expression, and 
regardless of the presence of PGE2, diminished PTGER4 mRNA 
levels. P4 thus appears to modulate the availability of PTGER2 and 
-4 in opposite directions.
Needless to say, taking into account the complexity of the decidu-
alization process and the lack of the natural cell-to-cell interaction 
in an in vitro system lacking different cellular compartments, as in 
any in vitro study, the findings obtained from cell culture studies 
need to be verified in vivo.
Undoubtedly, being responsible for the maintenance of canine 
pregnancy, and initiation of the luteolytic cascade by targeting 
placental decidual cells, the P4/PGR system is an important player 
regulating canine uterine and placental functions. During decidualiza-
tion, canine stromal cells appear to undergo mesenchymal-epithelial 
differentiation that is also typical of other decidualization models, 
as reflected in increased expression of COL4, ECM1 and strongly 
enhanced presence of CX43. Although P4 is considered to be a 
weaker spontaneous inducer of decidualization in the dog, our in 
vitro study suggests a direct involvement of P4-mediated pathways 
in canine decidualization by modulating the expression of several 
decidualization markers. Investigating them is certainly worth further 
attention as it could reveal important mechanisms underlying the 
regulation of canine embryo-maternal communication, determining 
the maintenance or termination of canine gestation and thereby 
bearing great clinical relevance.
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